TrialAnnals of internal medicine2022

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial.

Matthew G Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.